DUBLIN--(BUSINESS WIRE)--The "Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) - Global Forecast to 2022" report has been added to Research and Markets' offering.
The interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%.
Factors driving the growth of this market include rising geriatric population, improving healthcare infrastructure, and increasing incidence of CVD. On the other hand, the stringent regulatory scenario for these devices and the availability of effective first-line treatments is expected to limit market growth in the coming years.
Ad Statistics
Times Displayed: 3341
Times Visited: 6 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
The plaque modification devices market, by type, is categorized into thrombectomy devices and atherectomy devices. The thrombectomy devices segment is estimated to grow at the fastest rate during the forecast period. The increasing demand for technologically advanced thrombectomy devices is a key factor driving the growth of this market.
The angioplasty stents market is segmented drug-eluting stents, bare-metal stents, and bioresorbable stents. The bioresorbable stents segment is the fastest-growing segment of the global angioplasty stents market. Technological advancement in stents is driving the growth of this segment.
Geographically, the interventional cardiology devices market is dominated by North America, followed by Europe in 2017. Asia Pacific is estimated to grow at the fastest rate, due to infrastructural development in its healthcare systems, the rising burden of CVD, and increasing healthcare expenditure in APAC countries.
